Summary Box: Amgen CEO sees higher gross revenue in 2012 BusinessWeek MOMENTUM: Positive developments include last year's purchase of type A cancer vaccine developer and moves to protect semipermanent sales of top vender Enbrel, for psoriasis and rheumatoid arthritis, and blood disease treatment Epogen. MANAGEMENT MOVES: Along with ... Amgen's Next CEO Predicts Higher Revenue, More Markets ThirdAge all 158 news articles » Link To Article
No comments:
Post a Comment